Cargando…

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making

BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankolekar, Anshu, Vanneste, Ben G. L., Bloemen-van Gurp, Esther, van Roermund, Joep G., van Limbergen, Evert J., van de Beek, Kees, Marcelissen, Tom, Zambon, Victor, Oelke, Matthias, Dekker, Andre, Roumen, Cheryl, Lambin, Philippe, Berlanga, Adriana, Fijten, Rianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624887/
https://www.ncbi.nlm.nih.gov/pubmed/31296199
http://dx.doi.org/10.1186/s12911-019-0862-4
_version_ 1783434303054544896
author Ankolekar, Anshu
Vanneste, Ben G. L.
Bloemen-van Gurp, Esther
van Roermund, Joep G.
van Limbergen, Evert J.
van de Beek, Kees
Marcelissen, Tom
Zambon, Victor
Oelke, Matthias
Dekker, Andre
Roumen, Cheryl
Lambin, Philippe
Berlanga, Adriana
Fijten, Rianne
author_facet Ankolekar, Anshu
Vanneste, Ben G. L.
Bloemen-van Gurp, Esther
van Roermund, Joep G.
van Limbergen, Evert J.
van de Beek, Kees
Marcelissen, Tom
Zambon, Victor
Oelke, Matthias
Dekker, Andre
Roumen, Cheryl
Lambin, Philippe
Berlanga, Adriana
Fijten, Rianne
author_sort Ankolekar, Anshu
collection PubMed
description BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA for prostate cancer that is accurate and user-friendly. METHODS: We followed a user-centered design process consisting of five rounds of semi-structured interviews and usability surveys with topics such as informational/decisional needs of users and requirements for PDAs. Our user-base consisted of 8 urologists, 4 radiation oncologists, 2 oncology nurses, 8 general practitioners, 19 former prostate cancer patients, 4 usability experts and 11 healthy volunteers. RESULTS: Informational needs for patients centered on three key factors: treatment experience, post-treatment quality of life, and the impact of side effects. Patients and clinicians valued a PDA that presents balanced information on these factors through simple understandable language and visual aids. Usability questionnaires revealed that patients were more satisfied overall with the PDA than clinicians; however, both groups had concerns that the PDA might lengthen consultation times (42 and 41%, respectively). The PDA is accessible on http://beslissamen.nl/. CONCLUSIONS: User-centered design provided valuable insights into PDA requirements but challenges in integrating diverse perspectives as clinicians focus on clinical outcomes while patients also consider quality of life. Nevertheless, it is crucial to involve a broad base of clinical users in order to better understand the decision-making process and to develop a PDA that is accurate, usable, and acceptable. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12911-019-0862-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6624887
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66248872019-07-23 Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making Ankolekar, Anshu Vanneste, Ben G. L. Bloemen-van Gurp, Esther van Roermund, Joep G. van Limbergen, Evert J. van de Beek, Kees Marcelissen, Tom Zambon, Victor Oelke, Matthias Dekker, Andre Roumen, Cheryl Lambin, Philippe Berlanga, Adriana Fijten, Rianne BMC Med Inform Decis Mak Technical Advance BACKGROUND: Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA for prostate cancer that is accurate and user-friendly. METHODS: We followed a user-centered design process consisting of five rounds of semi-structured interviews and usability surveys with topics such as informational/decisional needs of users and requirements for PDAs. Our user-base consisted of 8 urologists, 4 radiation oncologists, 2 oncology nurses, 8 general practitioners, 19 former prostate cancer patients, 4 usability experts and 11 healthy volunteers. RESULTS: Informational needs for patients centered on three key factors: treatment experience, post-treatment quality of life, and the impact of side effects. Patients and clinicians valued a PDA that presents balanced information on these factors through simple understandable language and visual aids. Usability questionnaires revealed that patients were more satisfied overall with the PDA than clinicians; however, both groups had concerns that the PDA might lengthen consultation times (42 and 41%, respectively). The PDA is accessible on http://beslissamen.nl/. CONCLUSIONS: User-centered design provided valuable insights into PDA requirements but challenges in integrating diverse perspectives as clinicians focus on clinical outcomes while patients also consider quality of life. Nevertheless, it is crucial to involve a broad base of clinical users in order to better understand the decision-making process and to develop a PDA that is accurate, usable, and acceptable. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12911-019-0862-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-11 /pmc/articles/PMC6624887/ /pubmed/31296199 http://dx.doi.org/10.1186/s12911-019-0862-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Technical Advance
Ankolekar, Anshu
Vanneste, Ben G. L.
Bloemen-van Gurp, Esther
van Roermund, Joep G.
van Limbergen, Evert J.
van de Beek, Kees
Marcelissen, Tom
Zambon, Victor
Oelke, Matthias
Dekker, Andre
Roumen, Cheryl
Lambin, Philippe
Berlanga, Adriana
Fijten, Rianne
Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title_full Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title_fullStr Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title_full_unstemmed Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title_short Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
title_sort development and validation of a patient decision aid for prostate cancer therapy: from paternalistic towards participative shared decision making
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624887/
https://www.ncbi.nlm.nih.gov/pubmed/31296199
http://dx.doi.org/10.1186/s12911-019-0862-4
work_keys_str_mv AT ankolekaranshu developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT vannestebengl developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT bloemenvangurpesther developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT vanroermundjoepg developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT vanlimbergenevertj developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT vandebeekkees developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT marcelissentom developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT zambonvictor developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT oelkematthias developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT dekkerandre developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT roumencheryl developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT lambinphilippe developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT berlangaadriana developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking
AT fijtenrianne developmentandvalidationofapatientdecisionaidforprostatecancertherapyfrompaternalistictowardsparticipativeshareddecisionmaking